MOREADITH RANDALL (Chief Scientific Officer) sold 5.67K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.2K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/23/2025ACC: 0001301120-25-000037
Officer· Chief Scientific Officer
Since Feb 2026
-5.67K
Net shares
Net seller
$15.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.67K acquired · 11.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.67K
Price / share
$0.06
Trade value
$340.38
% of position
New position
12/22/2025
0.00→5.67K
Common Stock
Direct
Shares
−5.67K
Price / share
$2.67
Trade value
$15.17K
% of position
New position
12/22/2025
5.67K→0.00
Total
Net shares
+0.00
Net value
-$14.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | M · Option Exercise | +5.67K | $0.06 | $340.38 | New position | 0.00 | 5.67K |
| Common Stock Direct | 12/22/2025 | S · Sale | −5.67K | $2.67 | $15.17K | New position | 5.67K | 0.00 |
| Total | +0.00 | -$14.83K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
5.67K shares
Shares
−5.67K
Strike price
0.06
Held after
356.29K
Exercisable
—
12/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5.67K shares | 12/22/2025 | M · Option Exercise | −5.67K | 0.06 | — | 356.29K |